» Articles » PMID: 30881310

TRP Channels: Current Perspectives in the Adverse Cardiac Remodeling

Overview
Journal Front Physiol
Date 2019 Mar 19
PMID 30881310
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Calcium is an important second messenger required not only for the excitation-contraction coupling of the heart but also critical for the activation of cell signaling pathways involved in the adverse cardiac remodeling and consequently for the heart failure. Sustained neurohumoral activation, pressure-overload, or myocardial injury can cause pathologic hypertrophic growth of the heart followed by interstitial fibrosis. The consequent heart's structural and molecular adaptation might elevate the risk of developing heart failure and malignant arrhythmia. Compelling evidences have demonstrated that Ca entry through TRP channels might play pivotal roles in cardiac function and pathology. TRP proteins are classified into six subfamilies: TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin), TRPML (mucolipin), and TRPP (polycystin), which are activated by numerous physical and/or chemical stimuli. TRP channels participate to the handling of the intracellular Ca concentration in cardiac myocytes and are mediators of different cardiovascular alterations. This review provides an overview of the current knowledge of TRP proteins implication in the pathologic process of some frequent cardiac diseases associated with the adverse cardiac remodeling such as cardiac hypertrophy, fibrosis, and conduction alteration.

Citing Articles

Endomyocardial fibrosis: recent advances and future therapeutic targets.

Mocumbi A, Hotta V, Bukhman G, Ntusi N, Yacoub M, Correia-de-Sa P Nat Rev Cardiol. 2025; .

PMID: 40011660 DOI: 10.1038/s41569-025-01138-x.


The Pathogenic Mechanisms of and Novel Therapies for Lamin A/C-Related Dilated Cardiomyopathy Based on Patient-Specific Pluripotent Stem Cell Platforms and Animal Models.

Wu X, Lee Y, Lau Y, Au K, Tse Y, Ng K Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204134 PMC: 11357512. DOI: 10.3390/ph17081030.


Homotherapy for Heteropathy: A Molecular Mechanism of Poria Sini Decoction for Treatment of Liver Cancer and Chronic Heart Failure.

Zhao Z, Yue H, Cui X Evid Based Complement Alternat Med. 2024; 2024:9958258.

PMID: 38711438 PMC: 11073853. DOI: 10.1155/2024/9958258.


New Insights into the Reparative Angiogenesis after Myocardial Infarction.

Martin-Bornez M, Falcon D, Morrugares R, Siegfried G, Khatib A, Rosado J Int J Mol Sci. 2023; 24(15).

PMID: 37569674 PMC: 10418963. DOI: 10.3390/ijms241512298.


Progress on role of ion channels of cardiac fibroblasts in fibrosis.

Xing C, Bao L, Li W, Fan H Front Physiol. 2023; 14:1138306.

PMID: 36969589 PMC: 10033868. DOI: 10.3389/fphys.2023.1138306.


References
1.
Nilius B, Droogmans G . Ion channels and their functional role in vascular endothelium. Physiol Rev. 2001; 81(4):1415-59. DOI: 10.1152/physrev.2001.81.4.1415. View

2.
Bers D . Cardiac excitation-contraction coupling. Nature. 2002; 415(6868):198-205. DOI: 10.1038/415198a. View

3.
Montell C, Birnbaumer L, Flockerzi V, Bindels R, Bruford E, Caterina M . A unified nomenclature for the superfamily of TRP cation channels. Mol Cell. 2002; 9(2):229-31. DOI: 10.1016/s1097-2765(02)00448-3. View

4.
Launay P, Fleig A, Perraud A, Scharenberg A, Penner R, Kinet J . TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization. Cell. 2002; 109(3):397-407. DOI: 10.1016/s0092-8674(02)00719-5. View

5.
Pennekamp P, Karcher C, Fischer A, Schweickert A, Skryabin B, Horst J . The ion channel polycystin-2 is required for left-right axis determination in mice. Curr Biol. 2002; 12(11):938-43. DOI: 10.1016/s0960-9822(02)00869-2. View